JOCELYN CAMARET: Open Payments
NPI 1639885395 · VACAVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 52 payments from 18 companies in 2025. Trend: 2023 $31 · 2024 $1,708 · 2025 $1,169
Food & beverage: $1,144Education: $25
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $268 |
| GENZYME CORPORATION | 13 | $205 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Regeneron Healthcare Solutions, Inc. | 3 | $101 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Amgen Inc. | 3 | $67 |
| Ionis Pharmaceuticals, Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $30 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, EOHILIA, INSPIRE, DAWNZERA, NEFFY.
Industry payments across CA — which companies pay providers there.
